Literature DB >> 8629931

Acute gastric dilatation in Duchenne muscular dystrophy: a case report and review of the literature.

E S Bensen1, K M Jaffe, P I Tarr.   

Abstract

Duchenne muscular dystrophy (DMD) is the most common neuromuscular disorder of childhood. Its clinical characteristics that derive from skeletal muscle involvement have been well described. Less well known is that visceral smooth muscle is affected in DMD. We report a case of a 19-year-old man with DMD who presented with severe nonradiating epigastric pain. He was initially sent home from the emergency department with a diagnosis of costochondritis. Acute gastric dilation was not considered in the differential diagnosis despite supportive history, physical examination findings, and radiographs. The case illustrates the lack of familiarity by clinicians of the gastrointestinal manifestations of DMD, including gastric dilatation and intestinal pseudoobstruction. Following a case discussion, the literature relevant to acute gastric atony is reviewed.

Entities:  

Mesh:

Year:  1996        PMID: 8629931     DOI: 10.1016/s0003-9993(96)90043-x

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  10 in total

Review 1.  Progress in focus: recent advances in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2002-11-27       Impact factor: 4.304

2.  Chronic Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

Review 3.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

Review 4.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

5.  Acute gastric dilatation in a patient with spinal injury and multiple myeloma.

Authors:  Waheed Gul; Arif Qazi; Syed A Ali; Christopher Barde
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

6.  Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in mdx Dystrophic Mice.

Authors:  Kristy Swiderski; Suzannah J Read; Audrey S Chan; Jin D Chung; Jennifer Trieu; Timur Naim; René Koopman; Gordon S Lynch
Journal:  Nutrients       Date:  2021-12-20       Impact factor: 5.717

7.  The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.

Authors:  Arpana Sali; Gina M Many; Heather Gordish-Dressman; Jack H van der Meulen; Aditi Phadke; Christopher F Spurney; Avital Cnaan; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

8.  Non-operative treatment for perforated gastro-duodenal peptic ulcer in Duchenne muscular dystrophy: a case report.

Authors:  Justus-Martijn Brinkman; Jorg R Oddens; Barend J Van Royen; Jan Wever; Jan G Olsman
Journal:  BMC Surg       Date:  2004-01-08       Impact factor: 2.102

9.  Greater Colo-Rectal Activation Phenotype in Exercised mdx Mice.

Authors:  Marie Nearing; James Novak; Terence Partridge
Journal:  PLoS Curr       Date:  2018-05-02

10.  Spatiotemporal Mapping Reveals Regional Gastrointestinal Dysfunction in mdx Dystrophic Mice Ameliorated by Oral L-arginine Supplementation.

Authors:  Kristy Swiderski; Rebecka Bindon; Jennifer Trieu; Timur Naim; Shana Schokman; Mathusi Swaminathan; Anita J L Leembruggen; Elisa L Hill-Yardin; René Koopman; Joel C Bornstein; Gordon S Lynch
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.